Gryphon Investors to Acquire Revision Skincare

Gryphon Investors to Acquire Revision Skincare image

Gryphon Investors is set to acquire Revision Skincare and Goodier Cosmetics. The middle-market private equity firm has signed a definitive agreement to acquire the skincare company, with an anticipating closing date this year. Financial terms of the transaction were not disclosed. 

Revision Goodier's management team will continue to be led by CEO Maria Carell. As part of the transaction, a number of Gryphon Executive Advisors will join Gryphon Operating Partner Mike Ferry, Gryphon Deal Partner Matt Farron, and Gryphon Principal Eddie Douglas on the Board of Directors. The transaction marks Gryphon's third investment in skincare products and services and first investment in the physician dispensed skincare category.

For more than two decades, Revision Skincare® has provided dermatologists, plastic surgeons, and medical spas with clinically proven skincare products. Based in Irving, TX, Revision Skincare is sold in more than 10 countries. Since 1922,  Goodier Cosmetics has been a trusted developer and manufacturer in cosmetic and OTC topical skincare solutions. 

Gryphon Operating Partner Mike Ferry says, "Revision has a unique position as a high-growth independent company in a compelling market. Skincare consumers are becoming more discerning about the products they use, and we are excited to invest in Revision's mission to help bring carefully formulated and highly efficacious skincare products to a global customer base."

"We are delighted to partner with the team at Gryphon as we enter our next phase of growth. Gryphon is an ideal partner given their knowledge of skincare, consumer health, and professionally-endorsed brands, and their investment will allow us to accelerate the incredible momentum we have built over the last few years,” says Ms. Carell.

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free